Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia – PubMed
In patients treated in a PE, a neutropenic diet did not prevent major infection or death.
Related Articles
Home
Thank you for supporting the ASH Foundation. Your generosity enables the Foundation to provide critical support to the field of hematology through programs in resea…
CTG Labs – NCBI
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Paper: A Randomized Trial Demonstrates a 3-Shot Flu Vaccine Series Improves Protection over a Single Shot in Multiple Myeloma
Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical a nd Epidemiological: Addressing Hematologic and Immune Toxicities and the Status of Quad…
Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma
Bispecific antibodies (BsAbs) create an immunologic synapse between T cells and malignant cells, via T-cell surface marker CD3 and a tumor cell surface marker, activating…
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients
MicroabstractWe analyzed vaccination rates and associated outcomes of patients with multiple myelom in the INSIGHT MM study. Influenza vaccination in the prior 2 years and…
Prevention of infections including vaccination strategies in multiple myeloma
The American Journal of Hematology publishes research in blood diseases in humans & animal model, covering all hematological diseases including leukemia, hemostasis and thrombosis.
Program Guide – ASCO Meeting Program Guide
Christine Ho Roswell Park Comprehensive Cancer Center, Buffalo, NY Christine Ho, Paul K. Wallace, Kristopher Attwood, Sarah Parker, Hemn Mohammadpour, Megan Herr, George Chen, Joseph…
Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies
Purpose: This study sought to describe the changes in immune response to a third dose of either Pfizer’s or Moderna’s COVID-19 mRNA vaccine (3V) among…
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
Patients treated recently for a B-lymphoid malignancy are shown to have particularly high risks of severe COVID-19 compared to multiple control cohorts of patients with…